SCHEMBL7373754

SCHEMBL7373754

O=S(=O)(c1ccccc1)c1ccc(-c2c(-c3ccccc3)nn3ccncc23)nn1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.39
MAPK1 P28482 5/20 0.36
MAPK14 Q16539 2/20 0.36
MAPK3 P27361 1/20 0.36
ADORA1 P30542 2/20 0.35
AURKA O14965 2/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.33
PTGS2 P35354 1/20 0.33
EGFR P00533 1/20 0.33
RAF1 P04049 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
GSK3B P49841 1/20 0.33
ABCB1 P08183 1/20 0.32
ABCC1 P33527 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7367472 0.88 KDM4E (0.39) MAPK14AURKA
SCHEMBL7296061 0.86 IGF1R (0.51) IGF1RMAPK1MAPK14MAPK3ADORA1
SCHEMBL7364009 0.84 LMNA (0.37) PTGS2ABCB1ABCC1
SCHEMBL5673928 0.83 MAPK14 (0.40) MAPK14ADORA1AURKAPTGDR2PTGS2
SCHEMBL6818747 0.79 AURKA (0.39) IGF1RMAPK1MAPK14MAPK3AURKA
SCHEMBL7373757 0.78 PTGDR2 (0.37) IGF1RMAPK14ADORA1AURKAPTGDR2
SCHEMBL5671102 0.78 MAPK14 (0.50) MAPK14ADORA1PTGS2EGFRRAF1
SCHEMBL6821442 0.74 HTR6 (0.37) IGF1RMAPK1MAPK14AURKAPTGS2
SCHEMBL6822095 0.74 MAPK14 (0.39) IGF1RMAPK14ADORA1AURKAPTGDR2
SCHEMBL7369957 0.73 PDE3A (0.48) IGF1RMAPK1MAPK14MAPK3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244669-A1 PYRAZOLOPYRAZINES AND THEIR USE AS ADENOSINE ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-10-02 EP disclosed
WO-2001040230-A1 PYRAZOLOPYRAZINES AND THEIR USE AS ADENOSINE ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-07 WO disclosed